Novo Nordisk plans to invest $4.1 billion to build a second fill and finishing manufacturing facility in Clayton, N.C., as demand for weight-loss drugs show no signs of letting up.
Related Posts
Samsung Electronics Plans $7 Billion Share Buyback
The South Korean technology giant’s stock repurchase plan comes amid investor concerns over its flagship memory-chip business, which is missing out on the artificial intelligence […]
Arthur J. Gallagher to Acquire AssuredPartners for $13.45 Billion
Arthur J. Gallagher said that buying the insurance broker would expand its retail middle-market property and casualty focus across the U.S.
UnitedHealth Shares Dive After Health Giant Says 2025 Results Likely to Fall Short
The company estimates that its formal guidance for 2025 will top out at about $30 in earnings per share